EN
CN
EN
About Us
About Viva Biotech
Corporate Culture
History&Awards
Management Team
Environmental, Social and Governance (ESG)
Business Conduct and Ethics
CRO Services
Discovery Biology Services
Protein Expression and Purification
Membrane Protein Targeted Discovery Technology
Ultrasonic Crushing, High Pressure Homogenate Crushing
Affinity Chromatography Purification
Ion Exchange Purification
Gel Filtration Purification
Dialysis, Dilution Refolding
SDS-PAGE, WB, MS, SEC-MALS Detection
Structural Biology Services
X-ray Crystal Structure Analysis of Protein
Cryo-EM Technology Platform
Hit Discovery
V-DEL Platform
ASMS Technology
SPR Technology
Crystal Soaking Technology
Intact-MS Technology
HTS Technology
Bioassay
Biomolecular Interaction
ASMS Technology
SPR Technology
HDX-MS
Native-MS
Intact-MS
TSA Technology
X-ray Crystal Structure Analysis of Protein
Cryo-EM Single Particle Analysis
Microcrystal electron diffraction
Pharmacology & DMPK
Product Center
Cell-Lines
Crystal Structures
GPCR-Proteins
Antibody
Protein
Chemistry Services
Medicinal Chemistry
Synthetic Chemistry
Analytical Chemistry
Purification Preparation
Chemical Technology Platforms
PROTAC Technology
Polypeptide Technology
Light-catalyzed Reaction
Catalysis Screening Technology
Deuterium and Isotope Modification
Fluorescent Probes and Labeling
Fluorine Chemistry
Macrocyclic Chemistry
Nucleotide Chemistry
Antibody/Biologics R&D Services
Recombinant Protein Expression Platform
Antibody Discovery and Affinity Maturation
Assay Platform
Antibody Production and Identification Platform
Antigen-Antibody Structural Resolution Platform
PROTAC/Molecular Glue Services
Protein Preparation and Ternary Complex Structure Determination
PROTAC/Molecular Glues Screening
PROTAC Ternary Complex Kinetics (SPR)
PROTAC Degradation Assays and Ternary Complex Assays
PROTAC Molecule Design and Synthesis
ADME & PK/PD Studies of PROTAC Molecules
AIDD/CADD PROTAC Design
XDC Platform
XDC Conjugation and Quality Study
XDC Chemistry R&D
XDC Functional Studies
AIDD and CADD
Computational Chemistry Technology
Computational Biology Technology
Technology and Platform
CDMO Services
EFS Business
News
Company News
Events
Portfolio Highlights
Video Center
Careers
Working at VIVA
Total Rewards
Cutting-edge Laboratory
Investor Relations
Corporate Governance
Information Disclosure
Presentations & Webcasts
IR Newsletter
Investors Contact
Contact Us
News
Company News
Events
Portfolio Highlights
Video Center
Company News
Year
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Month
01
02
03
04
05
06
07
08
09
10
11
12
2025-05-14
Viva Biotech Launches the AI-Driven Drug Discovery Platform, Transforming New Drug R&D Logic, Enabling One-Stop Innovative Drug Discovery
The company's AI platform is transforming the once-impossible into achievable breakthroughs.
More
2025-05-12
Viva Biotech Continues to Drive Progress in Structural Biology: Contributes to a Novel PRMT5 Inhibitor Study in Journal of Medicinal Chemistry
Viva Biotech provided strong technical support for this structure-based drug discovery effort.
More
2025-03-28
Viva Biotech's Wholly-Owned Subsidiary Langhua Pharmaceutical Successfully Passes U.S. FDA On-Site Inspection
This is the fourth time that Langhua Pharmaceutical has undergone and passed the on-site inspection by the FDA.
More
2024-07-15
Unveiling the Magic of New Drug Modality Discovery: How Computational Chemistry and Artificial Intelligence Drive Structure-Based Drug Discovery and Mechanistic Study
2024-03-28
Viva Biotech (1873.HK) Announces 2023 Annual Results: Successful Implementation of Light-asset Strategy, Achieving Solid Growth and Promising Future
2024-03-20
Viva Biotech and Lonza Enter Licensing Agreement for Lonza's bYlok® Bispecific Pairing Technology
2024-02-01
AIxplorerBio published a research article in the J. Comput. Chem. on enhancing the efficiency of relative binding free energy calculation, with Dr. Yue Qian as the co-corresponding author.
2024-01-02
Unifying strength towards future: Viva Biotech's 2023 Milestone
2024-01-15
Viva Biotech was honored with "the Influential Preclinical CRO Company of the Year" award
2023-12-16
Viva Biotech announced approximately US$15 million in additional funding with ICD investment
2023-11-28
Viva Biotech awarded the Best Partner of 2023 Shanghai Makers Carnival
2023-11-20
Viva Biotech Secures Approximately US$ 210 Million Funding
2023-08-29
Everything You Need to Know about Viva Biotech 2023 Interim Results
2023-08-29
Viva Biotech (1873.HK) Announces 2023 Interim Results:Solid Growth in Main Business, Significant Rebound in Profitability
2023-06-16
Viva Biotech Announced Strategic Investors with an Investment of Approximately US$ 210 Million
<
1
2
3
4
5
6
>
Media contact:
vivapr@vivabiotech.com
Contact Us
About Us
Back
About Us
About Viva Biotech
Corporate Culture
History&Awards
Management Team
Environmental, Social and Governance (ESG)
Business Conduct and Ethics
CRO Services
Back
CRO Services
Discovery Biology Services
Back
Discovery Biology Services
Protein Expression and Purification
Back
Protein Expression and Purification
Membrane Protein Targeted Discovery Technology
Ultrasonic Crushing, High Pressure Homogenate Crushing
Affinity Chromatography Purification
Ion Exchange Purification
Gel Filtration Purification
Dialysis, Dilution Refolding
SDS-PAGE, WB, MS, SEC-MALS Detection
Structural Biology Services
Back
Structural Biology Services
X-ray Crystal Structure Analysis of Protein
Cryo-EM Technology Platform
Hit Discovery
Back
Hit Discovery
V-DEL Platform
ASMS Technology
SPR Technology
Crystal Soaking Technology
Intact-MS Technology
HTS Technology
Bioassay
Back
Bioassay
Biomolecular Interaction
Back
Biomolecular Interaction
ASMS Technology
SPR Technology
HDX-MS
Native-MS
Intact-MS
TSA Technology
X-ray Crystal Structure Analysis of Protein
Cryo-EM Single Particle Analysis
Microcrystal electron diffraction
Pharmacology & DMPK
Back
Pharmacology & DMPK
Product Center
Back
Product Center
Cell-Lines
Crystal Structures
GPCR-Proteins
Antibody
Protein
Chemistry Services
Back
Chemistry Services
Medicinal Chemistry
Synthetic Chemistry
Analytical Chemistry
Purification Preparation
Chemical Technology Platforms
Back
Chemical Technology Platforms
PROTAC Technology
Polypeptide Technology
Light-catalyzed Reaction
Catalysis Screening Technology
Deuterium and Isotope Modification
Fluorescent Probes and Labeling
Fluorine Chemistry
Macrocyclic Chemistry
Nucleotide Chemistry
Antibody/Biologics R&D Services
返回
Antibody/Biologics R&D Services
Recombinant Protein Expression Platform
Antibody Discovery and Affinity Maturation
Assay Platform
Antibody Production and Identification Platform
Antigen-Antibody Structural Resolution Platform
PROTAC/Molecular Glue Services
Back
PROTAC/Molecular Glue Services
Protein Preparation and Ternary Complex Structure Determination
PROTAC/Molecular Glues Screening
PROTAC Ternary Complex Kinetics (SPR)
PROTAC Degradation Assays and Ternary Complex Assays
PROTAC Molecule Design and Synthesis
ADME & PK/PD Studies of PROTAC Molecules
AIDD/CADD PROTAC Design
XDC Platform
Back
XDC Platform
XDC Conjugation and Quality Study
XDC Chemistry R&D
XDC Functional Studies
AIDD and CADD
Back
AIDD and CADD
Computational Chemistry Technology
Computational Biology Technology
Technology and Platform
CDMO Services
EFS Business
News
Back
News
Company News
Events
Portfolio Highlights
Video Center
Careers
Back
Careers
Working at VIVA
Total Rewards
Cutting-edge Laboratory
Investor Relations
Back
Investor Relations
Corporate Governance
Information Disclosure
Presentations & Webcasts
IR Newsletter
Investors Contact
Contact Us